DeepMed Research

UNIVERSITY OF SOUTHERN CALIFORNIA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1880-01-01

Employees: 10K

Market Cap: -

Website: http://startusc.com

Clinical Trials

Determining Depression Treatment Preferences of Low-Income Latinos in Primary Care Settings

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Collaborative care treatment
Behavioral: Enhanced usual care

First Posted Date: 2005-12-01

Last Posted Date: 2013-12-10

Lead Sponsor: University of Southern California

Target Recruit Count: 432

Registration Number: NCT00260169

Locations: 🇺🇸
LAC+USC Outpatient Department, Los Angeles, California, United States
🇺🇸
H. Claude Hudson Comprehensive Health Center, Los Angeles, California, United States
🇺🇸
USC Family Practice Center at California Hospital, Los Angeles, California, United States

Does Reducing Spasticity Permit an Increase in Strength?

Phase 2

Completed

Conditions: Spastic Diplegic Cerebral Palsy

First Posted Date: 2005-11-17

Last Posted Date: 2014-05-23

Lead Sponsor: University of Southern California

Target Recruit Count: 10

Registration Number: NCT00255073

Locations: 🇺🇸
Stanford University, Stanford, California, United States

PPI Versus Placebo in Severe Functional Heartburn

Not Applicable

Withdrawn

Conditions: GERD

Interventions: Drug: PPI

First Posted Date: 2005-09-22

Last Posted Date: 2017-04-14

Lead Sponsor: University of Southern California

Registration Number: NCT00222989

Locations: 🇺🇸
USC Keck School of Medicine, LA, California, United States

Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma

Phase 2

Terminated

Conditions: Mantle Cell Lymphoma

First Posted Date: 2005-09-16

Last Posted Date: 2014-05-22

Lead Sponsor: University of Southern California

Target Recruit Count: 30

Registration Number: NCT00183989

Locations: 🇺🇸
Norris Comprehensive Cancer Center, Los Angeles, California, United States

Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

Phase 2

Completed

Conditions: Ovarian Carcinoma
Peritoneal Neoplasms

Interventions: Drug: Docetaxel and Gemcitabine

First Posted Date: 2005-09-16

Last Posted Date: 2014-05-22

Lead Sponsor: University of Southern California

Target Recruit Count: 20

Registration Number: NCT00183794

Locations: 🇺🇸
Norris Comprehensive Cancer Center, Los Angeles, California, United States

Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.

Phase 2

Completed

Conditions: Prostate Adenocarcinoma

First Posted Date: 2005-09-16

Last Posted Date: 2014-05-22

Lead Sponsor: University of Southern California

Target Recruit Count: 20

Registration Number: NCT00183924

Locations: 🇺🇸
Norris Comprehensive Cancer Center, Los Angeles, California, United States

A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)

Phase 2

Terminated

Conditions: Breast Carcinoma

Interventions: Drug: Fulvestrant
Drug: Tamoxifen

First Posted Date: 2005-09-16

Last Posted Date: 2014-05-22

Lead Sponsor: University of Southern California

Target Recruit Count: 4

Registration Number: NCT00183963

Locations: 🇺🇸
Norris Comprehensive Cancer Center, Los Angeles, California, United States

Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy

Phase 1

Terminated

Conditions: Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia

First Posted Date: 2005-09-16

Last Posted Date: 2014-05-22

Lead Sponsor: University of Southern California

Target Recruit Count: 12

Registration Number: NCT00183950

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States

Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers

Phase 1

Completed

Conditions: Pancreatic Cancer
Gastric Cancer
Duodenum Cancer
Bile Duct Cancer

First Posted Date: 2005-09-16

Last Posted Date: 2014-05-22

Lead Sponsor: University of Southern California

Target Recruit Count: 22

Registration Number: NCT00183846

Locations: 🇺🇸
U.S.C./Norris Cancer Center, Los Angeles, California, United States

Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan

Phase 1

Completed

Conditions: Gastric Cancer
Adenocarcinoma

Interventions: Drug: irinotecan

First Posted Date: 2005-09-16

Last Posted Date: 2014-05-22

Lead Sponsor: University of Southern California

Target Recruit Count: 42

Registration Number: NCT00183859

Locations: 🇺🇸
U.S.C. / Norris Comprehensive Cancer Center, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy